News > Johnson & Johnson set to begin India trial of its single-shot vaccine
Johnson & Johnson set to begin India trial of its single-shot vaccine
E-News | 09/04/2021 11:11 PM | Click to read full article
The U.S. drugs and healthcare giant's vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa.
The news comes as some parts of India face a shortage of vaccine supplies just as the country of 1.3 billion battles the second wave of COVID-19 infections.
